Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[New treatments for impotence].

E Wespes1

  • 1Service d'Urologie, C.H.U. de Charleroi.

Revue Medicale De Bruxelles
|October 19, 1999
PubMed
Summary

New oral drugs and challenges in vascular surgery have changed impotence treatment. Healthcare providers must stay updated on managing erectile dysfunction for better patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Myeloperoxidase and Prostate volume: A preliminary study.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2018
Same author

Intriguing location of myeloperoxidase in the prostate: a preliminary immunohistochemical study.

The Prostate·2011
Same author

[Enuresis: treatments recognized by EBM].

Revue medicale de Bruxelles·2010
Same author

Erectile dysfunction and cardiovascular diseases.

Archivos espanoles de urologia·2010
Same author

Current approaches to erectile dysfunction and testosterone deficiency.

Minerva urologica e nefrologica = The Italian journal of urology and nephrology·2010
Same author

[Decrease ApoB/ApoA-1 ratio and cardiovascular risk improvement: a tadalafil pleiotropic effect? Preliminary study on healthy volunteers].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2008

Area of Science:

  • Urology
  • Andrology
  • Vascular Surgery

Background:

  • The therapeutic landscape for erectile dysfunction (ED) has evolved significantly.
  • Traditional surgical interventions, such as reconstructive vascular surgery, have shown suboptimal outcomes in certain patient populations.

Purpose of the Study:

  • To highlight the paradigm shift in managing patients with impotence.
  • To emphasize the need for healthcare professionals to be informed about current treatment modalities for erectile dysfunction.

Main Methods:

  • Review of current literature on oral pharmacotherapies for ED.
  • Analysis of outcomes data for reconstructive vascular surgery in ED patients.
  • Synthesis of evolving treatment guidelines for male sexual dysfunction.

Main Results:

  • Novel oral medications have emerged as a primary treatment option for erectile dysfunction.
  • Reconstructive vascular surgery for impotence yields variable and often disappointing results.
  • The management of impotence now requires a multi-faceted approach considering patient-specific factors.

Conclusions:

  • The advent of effective oral treatments has altered the first-line approach to impotence.
  • Physicians must adapt their therapeutic strategies to incorporate these advancements in erectile dysfunction management.
  • Awareness of evolving treatment options is crucial for optimizing care for impotent patients.

Related Experiment Videos